BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10816572)

  • 1. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains.
    Galbiati F; Volonte D; Brown AM; Weinstein DE; Ben-Ze'ev A; Pestell RG; Lisanti MP
    J Biol Chem; 2000 Jul; 275(30):23368-77. PubMed ID: 10816572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
    Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
    J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
    Hsu SC; Galceran J; Grosschedl R
    Mol Cell Biol; 1998 Aug; 18(8):4807-18. PubMed ID: 9671490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt-independent beta-catenin transactivation in tumor development.
    Lu Z; Hunter T
    Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
    Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis.
    Vleminckx K; Kemler R; Hecht A
    Mech Dev; 1999 Mar; 81(1-2):65-74. PubMed ID: 10330485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
    Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
    J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
    Jho EH; Zhang T; Domon C; Joo CK; Freund JN; Costantini F
    Mol Cell Biol; 2002 Feb; 22(4):1172-83. PubMed ID: 11809808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
    Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
    Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct regulation of the Xenopus engrailed-2 promoter by the Wnt signaling pathway, and a molecular screen for Wnt-responsive genes, confirm a role for Wnt signaling during neural patterning in Xenopus.
    McGrew LL; Takemaru K; Bates R; Moon RT
    Mech Dev; 1999 Sep; 87(1-2):21-32. PubMed ID: 10495268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression.
    Gradl D; Kühl M; Wedlich D
    Mol Cell Biol; 1999 Aug; 19(8):5576-87. PubMed ID: 10409747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
    Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
    Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulating the regulators: routing the Wnt-beta-catenin--Lef signals.
    Widelitz RB
    J Invest Dermatol; 2004 Aug; 123(2):VIII-X. PubMed ID: 15245452
    [No Abstract]   [Full Text] [Related]  

  • 16. Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts.
    Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K
    Int J Cancer; 2002 Jun; 99(5):681-8. PubMed ID: 12115501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of beta-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification.
    Kitagaki J; Iwamoto M; Liu JG; Tamamura Y; Pacifci M; Enomoto-Iwamoto M
    Osteoarthritis Cartilage; 2003 Jan; 11(1):36-43. PubMed ID: 12505485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
    Papkoff J; Aikawa M
    Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.